Daytrana Patch
Links shared publicly online about this topic
Daytrana patches recalled by Shire - MPR
empr.com — “Shire is voluntarily recalling five lots and withdrawing one lot of Daytrana (methylphenidate transdermal system) due to difficulty removing the release liner from some of the patches.” View full resource at empr.com
Most Recently Shared on December 3, 2009 at 4:58 pm By:
MPR News: Daytrana patches recalled by Shire: Shire is voluntarily recalling five lots and withdrawing one lot of D... http://bit.ly/6nkaAK
Shire issues recall of Daytrana patches - MPR
empr.com — “Shire has issued a voluntary recall of 39 lots of Daytrana (methylphenidate) transdermal patches because of difficulties removing the release liner.” View full resource at empr.com
Most Recently Shared on March 20, 2009 at 3:45 pm By:
Shire issues recall of Daytrana patches : Shire has issued a voluntary recall of 39 lots of Daytrana (methylphen.. http://tinyurl.com/cgh3wa
Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug? | BNET Pharma Blog | BNET
industry.bnet.com — “Shire (SHPGY) has voluntarily recalled the Daytrana ADHD patch citing problems with patients removing the liner on the back. It is not a safety issue,” View full resource at industry.bnet.com
Most Recently Shared on December 7, 2009 at 4:49 pm By:
Jim Edwards Health Communicator
Shire's Daytrana Patch Recall Is 8th So Far: Time to Pull the Plug?: Shire (SHPGY) has voluntarily recalled the Day... http://bit.ly/5d1A9H
Shire receives FDA approval of Daytrana for ADHD in adolescents
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include ” View full resource at news-medical.net
Most Recently Shared on July 7, 2010 at 5:40 am By:
Shire receives FDA approval of Daytrana for ADHD in adolescents: Shire plc, the global specialty biopharmaceutical... http://bit.ly/atTr4s
FDA Approves Daytrana (methylphenidate transdermal system) CII for the Treatment of ADHD in Adolescents
drugs.com — “Daytrana (methylphenidate) is used for attention deficit hyperactivity disorder. Information from Drugs.com includes Daytrana side effects, interactions, indications” View full resource at drugs.com
Most Recently Shared on July 8, 2010 at 7:20 pm By:
FDA Approves Daytrana for the Treatment of ADHD in Adolescents - http://bit.ly/aZ1hIE
Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire - Drugs.com MedNews
drugs.com — “First and Only Patch for ADHD Now to be Marketed and Sold by Noven Therapeutics Oct 1, 2010 - Noven Pharmaceuticals, Inc. today announced that it has completed” View full resource at drugs.com
Most Recently Shared on October 1, 2010 at 4:19 pm By:
Drugs and Devices OW OW Health
Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire: First and Only P... http://bit.ly/9YGHxH #drug
Goodbye to the ADHD Patch: After 9 Recalls and a Federal Probe, Shire Gives Up | BNET
bnet.com — “Back in December, I suggested that Shire (SHPGY) should ditch Daytrana, its ADHD patch for kids, because the liners on the device malfunctioned so fre” View full resource at bnet.com
Most Recently Shared on August 11, 2010 at 8:39 pm By:
Jim Edwards Health Communicator
Goodbye to the ADHD Patch: After 9 Recalls and a Federal Probe, Shire Gives Up: Back in December, I suggested that... http://bit.ly/9tPNeV
Subscription Center - News Archive
pharmalive.com — “Subscription Center - News Archive” View full resource at pharmalive.com
Most Recently Shared on December 3, 2009 at 6:40 pm By:
PharmaLive Pharma and Health News
Shire Announces Second Limited Recall of ADHD Patch Daytrana-http://tinyurl.com/yz7jqky
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Jim Edwards
Writer for CBS Interactive's BNET, Adweek and Brandweek.
Advertisement
